99 related articles for article (PubMed ID: 5382524)
21. [Further clinical experiences with ornithine aspartate in liver diseases].
Wotzka R; Weber D
Ther Ggw; 1972 Mar; 111(3):400-12. PubMed ID: 5024593
[No Abstract] [Full Text] [Related]
22. [Research on the hepatoprotective effect of 1-amino acids involved in the Krebs-Henseleit cycle associated with vitamins].
Rossi L; Laghi V; Cavallaro A
Minerva Med; 1968 Sep; 59(75):3919-30. PubMed ID: 4234452
[No Abstract] [Full Text] [Related]
23. [Effects of the arginine-ornithine combination on the arterial ammonia levels in chronic liver diseases and hepatic coma].
Miszputen SJ; Ganc AJ; Costa AA; Reibscheid S; Vilela MP
AMB Rev Assoc Med Bras; 1968 Jul; 14(7):117-22. PubMed ID: 5304250
[No Abstract] [Full Text] [Related]
24. [DETERMINATION OF THE AMINO ACIDS OF THE UREOPOIETIC CYCLE OF KREBS-HENSELEIT: L-ARGININE, L-ORNITHINE AND L-CITRULLINE].
CAVICCHINI G; FAZI L; ALMIRANTE L
Boll Chim Farm; 1964 Jan; 103():65-8. PubMed ID: 14131379
[No Abstract] [Full Text] [Related]
25. [Experiences with ornithine-aspartate in liver diseases].
Aschke J
Med Welt; 1969 Mar; 12():657-62. PubMed ID: 5767441
[No Abstract] [Full Text] [Related]
26. [Influence of L-arginine supplementation on the plasma amino acid spectrum in burn patients].
Lu SL; Ge K; Xie T; Jin SW; Shi JX
Zhonghua Shao Shang Za Zhi; 2005 Aug; 21(4):247-50. PubMed ID: 16185403
[TBL] [Abstract][Full Text] [Related]
27. [Controlled clinical trial of arginine malate associated with cytidine and uridine in secondary hepatopathies].
Rampazzo F
Minerva Med; 1974 Feb; 65(15):838-49. PubMed ID: 4826131
[No Abstract] [Full Text] [Related]
28. [Therapeutic action of arginine-thiazolidine-carboxylate (ATCA) as evaluated by liver function tests].
Alvisĭ V; D'Ambrosi A; Lo Ponte A; Tampieri ML; Tralli M
Arch Sci Med (Torino); 1980; 137(4):731-8. PubMed ID: 7018458
[TBL] [Abstract][Full Text] [Related]
29. [Therapy of hyperammoniemia].
Nordmann R
Dtsch Med Wochenschr; 1969 Jan; 94(5):230-1. PubMed ID: 5762228
[No Abstract] [Full Text] [Related]
30. Citrulline, Viagra and BiDil--bad medicine.
Czp A
Altern Med Rev; 2005 Dec; 10(4):265-7. PubMed ID: 16400750
[No Abstract] [Full Text] [Related]
31. [Clinical experiences in liver diseases (specially in patients with fatty liver due to alcoholism and food poisoning) under monotherapy with ornithine aspartate].
Hunold W
Z Allgemeinmed; 1973 Apr; 49(10):469-72. PubMed ID: 4580434
[No Abstract] [Full Text] [Related]
32. [On the treatment of various liver diseases by oral administration of arginine glucose-1-phosphate].
Arrigo A
Clin Ter; 1967 Dec; 43(6):523-41. PubMed ID: 5617980
[No Abstract] [Full Text] [Related]
33. An important role for pentose cycle in the synthesis of citrulline and proline from glutamine in porcine enterocytes.
Wu G
Arch Biochem Biophys; 1996 Dec; 336(2):224-30. PubMed ID: 8954569
[TBL] [Abstract][Full Text] [Related]
34. [Hepatoprotective drugs. Clinical results of the use of a sulfhydryl-methylating preparation].
Rapino P; Marulli R; Rapex G; Della Lunga S; Sabatino P
Minerva Med; 1982 Oct; 73(40):2853-60. PubMed ID: 7133498
[No Abstract] [Full Text] [Related]
35. [Reye's syndrome: pathogenetic problems (author's transl)].
Sabetta G; Castro M; Donfrancesco A; Castelli P; Lucidi V; Lubrano R; Ruberto U; Qaddourah M
Pediatr Med Chir; 1981; 3(6):555-7. PubMed ID: 7343954
[TBL] [Abstract][Full Text] [Related]
36. Ask the doctor. My husband is taking arginine and citrulline supplements because he read that they will protect his heart and arteries. Should I try these supplements, too, or is this a waste of money?
Creager MA
Harv Heart Lett; 2009 Apr; 19(8):7. PubMed ID: 19681202
[No Abstract] [Full Text] [Related]
37. [Effects of administration of arginine thiazolidinecarboxylate in liver pathology of various origins. Results of a multicenter study].
Gasbarrini G; Bernardi M
Minerva Dietol Gastroenterol; 1982; 28(2):143-52. PubMed ID: 7099448
[No Abstract] [Full Text] [Related]
38. Therapeutic use of citrulline in cardiovascular disease.
Romero MJ; Platt DH; Caldwell RB; Caldwell RW
Cardiovasc Drug Rev; 2006; 24(3-4):275-90. PubMed ID: 17214603
[TBL] [Abstract][Full Text] [Related]
39. [Personal experiences in the treatment of internal diseases with ornithine aspartate].
Perinović M; Robović Z; Grujić M; Ljubojević S
Med Arh; 1969; 23(3):29-32. PubMed ID: 5200044
[No Abstract] [Full Text] [Related]
40. [Recent findings in drug treatment of liver disease patients with ornithine-carbamyl-transferase (OCT). Personal experience].
Alvisi V; Tralli M; Tampieri ML; Lo Ponte A; D'Ambrosi A
Minerva Dietol Gastroenterol; 1982; 28(4):335-40. PubMed ID: 7167246
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
